Ignite Creation Date:
2024-10-26 @ 3:40 PM
Last Modification Date:
2024-10-26 @ 3:40 PM
Study NCT ID:
NCT06600334
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-09-13
Brief Title:
Prevalence of Osteoporosis Among Inflammatory Bowel Disease Patients in Assiut University Hospitals
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Prevalence of Osteoporosis Among Inflammatory Bowel Disease Patients in Assiut University Hospitals
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
the prevalence of osteoporosis in patients with inflammatory bowel disease in Assiut University Hospitals
Detailed Description:
Inflammatory bowel disease IBD includes ulcerative colitis UC and Crohns disease CD 1 There has been a global rise in the incidence of IBD over the last few decades 2 In the course of this disease apart from the involvement of the gastrointestinal tract up to 50 of patients may also have extraintestinal manifestations EIMs One of them may be osteoporosis OST which is present in over half of IBD patients this constitutes a significant problem due to the increased risk of fractures especially non-traumatic fractures3 Known risk factors for OST in IBD include the persistence of chronic inflammation treatment with glucocorticosteroids extensive range of the disease previous resection of the small intestine arthralgia and current nutritional deficiencies Some risk factors are similar to those found in the general population such as age smoking or low physical activity3 The pathogenesis of osteoporosis is multifactorial and comprises such elements as steroid therapy low body mass index BMI malnutrition genetic predispositions and vitamin D deficiency 4 Given that the gastroenterologist is often regarded as the main provider for IBD patients gastroenterologists and primary care physicians are equally responsible to recommend preventive measures and screening for osteoporosis in addition to other healthcare maintenance issues5 Dual energy X-ray absorptiometry DEXA scans are globally recognised as the screening tool for low BMD 6 The Z and T scores are used to establish the diagnosis of osteoporosis osteopenia or low BMD according to the 2019 International Society of Clinical Densitometry official position for adults7
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None